Confirmation of Tube Placement in Newborns

September 11, 2024 updated by: University of Alberta

Tracheal intubation remains a common procedure in the neonatal intensive care unit (NICU) and the delivery room (DR).

Current guidelines recommend Estimation of correct endotracheal tube (ETT) insertion Our hospital policy recommends to estimate the correct depth (cm) of tube placement by measuring the nasal-ear-tragus length using the "7-8-9 rule" when the endotracheal tube is placed orally. Using this formula an infant weighing 1kg would be intubated to a depth of 7cm, a 2kg infant to a depth of 8cm, and a 3kg infant to a depth of 9cm from the upper lip.

With the new 2015 guidelines, ETT depth is determined by measuring the newborn's nasal septum-tragus length (NTL) and adding 1cm or by using the "initial endotracheal tube insertion depth" table. The NTL is described as the distance from the base of the nasal septum to the tragus of the ear.

However, studies using NTL reported that using this technique only resulted in correct ETT placement in 56% of cases.

Every ETT has markings on the tube, which are called vocal cord markings, which are to be used to provide a guidance to how deep to place the ETT into the trachea. There has been npc study to compare the vocal cord markings with the current approach of NTL.

The current study aims to determine if the use of vocal cord markings during intubation increases percentage of correct endotracheal tube placement compared to NTL in preterm and term infants.

Study Overview

Study Type

Interventional

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Alberta
      • Edmonton, Alberta, Canada, T5H 3V9
        • Royal Alexandra Hospital

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

No older than 3 months (Child)

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • All infants (term and preterm) born at The Royal Alexandra Hospital who require endotracheal intubation in the delivery room or/and Neonatal Intensive Care Unit will be eligible.

Exclusion Criteria:

  • Infants will be excluded if their parents refuse to give consent to this study.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Triple

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Active Comparator: Nostril-Tragus-Length

Endotracheal tube depth is determined by measuring the newborn's nasal septum-tragus length (NTL) and adding 1cm.

The NTL is described as the distance from the base of the nasal septum to the tragus of the ear.

Experimental: Vocal cord markings
The endotracheal tube has markings on the tube, which are called vocal cord markings, which will be used to provide a guidance to how deep to place the ETT into the trachea.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Time Frame
Number of endotracheal tubes correctly placed within the trachea
Time Frame: within 30 minutes after endotracheal intubation
within 30 minutes after endotracheal intubation

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Mortality in the Neonatal Intensive Care Unit
Time Frame: 0-200 days
We will record the number of infants who die during their admission
0-200 days
Necrotizing Enterocolitis
Time Frame: 0-200 days
We will record the number of infants who are diagnosed with Necrotizing Enterocolitis
0-200 days
Patent Ductus Arteriosus
Time Frame: 0-200 days
We will record the number of infants who are diagnosed with Patent Ductus Arteriosus
0-200 days
Intraventricular hemorrhage all grades
Time Frame: 0-200 days
We will record the number of infants who are diagnosed with intraventricular hemorrhage
0-200 days
Bronchopulmonary Dysplasia at
Time Frame: 36 weeks corrected gestational age
We will record the number of infants who are diagnosed with Bronchopulmonary Dysplasia
36 weeks corrected gestational age
Changes in oxygen saturation during intubation procedure
Time Frame: 0 to 60 seconds
During intubation we will record the lowest oxygen saturation
0 to 60 seconds
Changes in Heart rate during intubation procedure
Time Frame: 0 to 60 seconds
During intubation we will record the lowest heart rate.
0 to 60 seconds
Duration of Intubation procedure
Time Frame: 0 to 60 seconds
During Intubation, we will measure time from end of mask ventilation to connection of the ventilation device to ETT
0 to 60 seconds
Airway injury observed during intubation (including blood, swollen cords, vocal cord redness)
Time Frame: 0 to 60 seconds
Observed by the person who performs the intubation by looking for blood, swollen cords, redness. There is no score or questionnaire. The operator will only assess these with yes or no
0 to 60 seconds

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Georg Schmolzer, University of Alberta

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

July 4, 2022

Primary Completion (Estimated)

December 31, 2024

Study Completion (Estimated)

March 31, 2025

Study Registration Dates

First Submitted

January 31, 2022

First Submitted That Met QC Criteria

January 31, 2022

First Posted (Actual)

February 8, 2022

Study Record Updates

Last Update Posted (Actual)

September 19, 2024

Last Update Submitted That Met QC Criteria

September 11, 2024

Last Verified

April 1, 2022

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

YES

IPD Plan Description

Investigators can contact the PI to discuss to use the collected data

IPD Sharing Supporting Information Type

  • STUDY_PROTOCOL
  • ICF
  • CSR

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Respiratory Distress Syndrome

Clinical Trials on Nostril-Tragus-Length

Subscribe